Organigram Holdings | OGI - Current Liabilities


Organigram Holdings reported CAD107.28M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Acasti Pharma USD 1.61M 364K Sep/2026
Akebia Therapeutics USD 162.35M 1.48M Sep/2026
Alaunos Therapeutics USD 864K 269K Jun/2026
Aurora Cannabis CAD 73.43M 6.5M Jun/2026
Avita Medical AUD 68.71M 6.04M Jun/2026
Canopy Growth CAD 166.75M 8.31M Jun/2026
Cronos Group USD 67.59M 11.23M Sep/2026
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Moderna USD 2.03B 506M Sep/2026
Organigram Holdings CAD 107.28M 18.54M Jun/2026
Organon & Co USD 2.65B 36M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Tectonic Therapeutic USD 10.37M 2.59M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
Viatris USD 6.64B 290.7M Sep/2026
Xeris Pharmaceuticals USD 134.48M 55.09M Sep/2026